GRPH 3.95 beauty of trading didn’t know there was a phase 3 for loss of near vision. That impacts every human being in the world so a good one for sure.. Thanks Volcano for alert..
The lead programs of the combined company will address presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over the age of 45. The combined company is expected to trade on Nasdaq under the ticker symbol "LENZ."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.